4 HIV drugs inhibit retrovirus tied to prostate cancer, chronic fatigue

04/1/2010 | Bloomberg Businessweek

U.S. researchers learned that four HIV medicines target the xenotropic murine leukemia virus-related virus, a retrovirus that possibly causes prostate cancer and chronic fatigue syndrome, when administered as combination therapies. The drug cocktails involving raltegravir, zidovudine, tenofovir disoproxil fumarate and a compound labeled L-00870812 "might also have the added benefit of delaying or even preventing the virus from mutating into forms that are drug-resistant," a study author said.

View Full Article in:

Bloomberg Businessweek

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
White Plains, NY
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ